Supporting Heart Health L-Carnitine has been shown to decrease symptoms of heart conditions, improve heart function, and reduce the risk of heart failure
Parkinson disease (PD) PD is the second leading neuronal condition among the elderly, and its prevalence is predicted to rise as the aging population
The between-subject random effect was mouse, and the within-subject repeated measure was preparation condition
Interestingly, among the CV outcomes trials with SGLT2 inhibitors, the EMPA REG OUTCOME trial, in which almost all patients had a history of CV events at baseline, showed marked reduction in all-cause mortality and CV death [1]
The results indicated the significant loss of IGF1R in OPL, inner plexiform layer (IPL), and ganglion cell layer, and some residual IGF-1R expression in the RIS (Fig